ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 60 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2017. The put-call ratio across all filers is 1.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,484,169 | +46.3% | 687,911 | +94.1% | 0.01% | +50.0% |
| Q2 2023 | $12,637,726 | +1858389.1% | 354,395 | +2014.7% | 0.00% | – |
| Q4 2022 | $680 | -99.9% | 16,759 | 0.0% | 0.00% | – |
| Q3 2022 | $554,000 | -55.0% | 16,759 | -52.0% | 0.00% | – |
| Q2 2022 | $1,230,000 | -54.1% | 34,943 | -40.0% | 0.00% | -100.0% |
| Q1 2022 | $2,677,000 | -66.7% | 58,219 | -52.0% | 0.00% | -50.0% |
| Q4 2021 | $8,043,000 | -18.5% | 121,289 | -23.3% | 0.00% | -33.3% |
| Q3 2021 | $9,870,000 | -45.7% | 158,090 | -28.0% | 0.00% | -50.0% |
| Q2 2021 | $18,184,000 | +28.8% | 219,588 | +3.1% | 0.01% | +20.0% |
| Q1 2021 | $14,122,000 | -20.8% | 213,076 | -8.3% | 0.01% | -16.7% |
| Q4 2020 | $17,826,000 | +26.2% | 232,300 | -29.2% | 0.01% | 0.0% |
| Q3 2020 | $14,125,000 | +9.7% | 328,015 | +10.1% | 0.01% | 0.0% |
| Q2 2020 | $12,871,000 | +226.0% | 298,058 | +117.2% | 0.01% | +200.0% |
| Q1 2020 | $3,948,000 | -56.1% | 137,233 | -3.2% | 0.00% | -33.3% |
| Q4 2019 | $8,990,000 | +659.3% | 141,697 | +237.3% | 0.00% | – |
| Q3 2019 | $1,184,000 | +39.3% | 42,010 | -5.3% | 0.00% | – |
| Q3 2018 | $850,000 | +41.0% | 44,358 | 0.0% | 0.00% | – |
| Q2 2018 | $603,000 | +88.4% | 44,358 | 0.0% | 0.00% | – |
| Q1 2018 | $320,000 | +96.3% | 44,358 | 0.0% | 0.00% | – |
| Q4 2017 | $163,000 | -15.1% | 44,358 | 0.0% | 0.00% | – |
| Q3 2017 | $192,000 | +860.0% | 44,358 | +252.2% | 0.00% | – |
| Q2 2017 | $20,000 | -13.0% | 12,593 | 0.0% | 0.00% | – |
| Q1 2017 | $23,000 | – | 12,593 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |